MRD testing promises sharper DLBCL response tracking than PET scans, cutting false positives, biopsies, and guiding therapy ...

Stage 1 mixed cellularity Hodgkin lymphoma is often highly treatable, and many patients achieve long-term remission after frontline therapy. Advances in chemotherapy, radiation techniques and targeted ...

Shawn Williams, General Manager and Head Coach Las Vegas Desert Dogs and Jade Hamilton, / Cure 4 The Kids Foundation patient joined us to talk about The Las Vegas Desert Dogs annual Tucker Out ...

Christopher J. Schaber, PhD, Chairman, President, and Chief Executive Officer of Soligenix (NASDAQ: SNGX), discusses the ...

Giahan Tang thought she was finally finding stability after college when unusual symptoms led to a shock diagnosis of stage 4 diffuse large B-cell lymphoma After an ER visit initially blamed on an ...

Real-time ctDNA MRD testing guides early chemo de-escalation in diffuse large B-cell lymphoma, aiming to cut toxicity without losing cure rates. In an interview with Targeted Oncology, Hua-Jay “Jeff” ...

New Delhi: At one time it was believed that DNA mutations were the sole cause for cancer. It is now recognised that cancer is a multifactorial disease influenced by genetics, gene regulation, ...

As artificial intelligence (AI) tools continue to proliferate, they are becoming a go-to search tool for patients, providers, and caregivers. Blood cancer patients are using AI in oncology to help ...

Choreographer Jacob Jonas' Stage 4 cancer diagnosis and subsequent battle back to health is reflected in the premiere of a trilogy of new work at BroadStage.

Announced data from cohort 4 of soquelitinib atopic dermatitis Phase 1 trial demonstrating positive safety and efficacy results, including in ...

Readers will learn how veterinary oncologists stage and treat canine lymphoma using modern multi-agent chemotherapy and palliative care.

Pivotal, Randomized Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell Lymphoma (LBCL) Positions Company at the Forefront of MRD-Guided ...